Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-05-02 @ 12:34 PM
Study NCT ID:
NCT00330369
Status:
COMPLETED
Last Update Posted:
2014-03-18
First Post:
2006-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
Sponsor:
Gilead Sciences
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DAR-311
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None